Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UPC | US
-1.13
-67.43%
Healthcare
Drug Manufacturers-Specialty & Generic
31/12/2023
13/09/2024
0.54
1.12
1.26
0.38
Universe Pharmaceuticals INC a pharmaceutical company engages in the development manufacturing marketing distribution and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers including biomedical drugs medical instruments traditional Chinese medicine pieces products and dietary supplements. Its customers include pharmaceutical companies hospitals clinics and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
384.3%1 month
277.4%3 months
185.7%6 months
163.9%-
-
0.33
0.14
0.10
0.31
0.70
-
-3.02M
11.48M
11.48M
-
-26.56
-82.00
-13.20
-14.34
1.64
13.89
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.01
Range1M
3.52
Range3M
3.94
Rel. volume
6.58
Price X volume
16.58M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 0.968 | 12.51M | 4.09% | n/a | 76.81% |
Guardion Health Sciences Inc | GHSI | Drug Manufacturers-Specialty & Generic | 9.91 | 12.16M | -2.08% | n/a | 0.00% |
Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 1.29 | 7.28M | 4.88% | n/a | 13.20% |
Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 2.29 | 4.84M | -2.14% | n/a | 222.75% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.81 | 4.48M | 0.36% | 0.07 | 0.00% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.3643 | 3.58M | -0.84% | n/a | 83.11% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.5 | 3.57M | 10.41% | n/a | 8.44% |
Evoke Pharma Inc | EVOK | Drug Manufacturers-Specialty & Generic | 4.31 | 3.21M | 2.86% | 0.04 | 187.62% |
SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 1.7 | 3.20M | 6.25% | n/a | 144.16% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 1.02 | 2.60M | 4.42% | n/a | 4.26% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.7456 | 10.41M | 7.76% | n/a | 422.08% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.07 | 10.31M | 35.44% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5337 | 4.94M | 18.60% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.31 | 3.62M | 1.55% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2475 | 3.40M | 15.12% | n/a | 0.97% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0133 | 1.20M | 10.83% | n/a | -37.05% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.7797 | 447.17K | -48.02% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.21 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.31 | - | Cheaper |
Ent. to Revenue | 0.70 | - | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 0.33 | 12.81 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 185.74 | - | Riskier |
Debt to Equity | 0.14 | -0.93 | Expensive |
Debt to Assets | 0.10 | 0.45 | Cheaper |
Market Cap | 11.48M | - | Emerging |